71610 0022 45
Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-022
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure-01 (Figure 01)
Figure-02 (Figure 02)
The text appears to be a table or graph showing the cumulative hazard percentage at different time intervals over a four-year follow-up period. One of the entries includes information about Atorvastatin and a hazard ratio. Without additional context, it is unclear what this information is being used to evaluate or predict.*
Figure-03 (Figure 03)
This is a table or graph that shows the percentage of subjects experiencing "E vert" after taking Horvastatin 10 mg and Sorvastatin 80 mg. The table or graph also shows a hazard ratio of 0.78 (with a confidence interval of 0.69-0.89) and a p value of 0.0002 for the two treatments. The x-axis represents the time to first major cardiovascular endpoint in years.*
Chemical-structure (Chemical Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
